Geron Corp (GERN): R&D Expense
$71.43M
Year ended 2025-12-31
$71.61M
Trailing 12 months to 2026-06-30
-9.2%
3-year compound annual growth
+6.8%
5-year compound annual growth
+14.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $71.43M | -31.1% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $103.74M | -17.0% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $125.05M | +30.9% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $95.52M | +11.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $85.73M | +66.5% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $51.49M | -1.1% | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | $52.07M | +287.7% | 2022-03-10, From 2019-01-01 |
| 2018-12-31 | $13.43M | +21.7% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $11.03M | -38.9% | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | $18.05M | +1.2% | 2019-03-07, From 2016-01-01 |
| 2015-12-31 | $17.83M | -13.9% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $20.71M | -10.6% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $23.16M | -54.9% | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | $51.37M | -25.9% | 2015-03-11, From 2012-01-01 |
| 2011-12-31 | $69.32M | +12.4% | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | $61.69M | +7.1% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $57.62M | n/a | 2012-03-07, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Geron Corp (GERN) | 2025-12-31 | $71.43M | -31.1% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $25.99M | -9.9% |
| Edgewise Therapeutics, Inc. (EWTX) | 2025-12-31 | $151.39M | +19.2% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $115.11M | +16.1% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $97.58M | +49.4% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $44.54M | -11.4% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $206.01M | -5.3% |
| Olema Pharmaceuticals, Inc. (OLMA) | 2025-12-31 | $157.70M | +26.6% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $145.64M | +75.2% |
Compare GERN, LAB, EWTX, NUVB side by side · Screen every company in Pharmaceutical Preparations ↗